Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 4,620 Shares

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at $21,275,217.60. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Philip Mazzara also recently made the following trade(s):

• On Monday, November 17th, Philip Mazzara sold 4,620 shares of Astera Labs stock. The shares were sold at an average price of $144.69, for a total value of $668,467.80.
• On Wednesday, October 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00.
• On Thursday, August 28th, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00.

Astera Labs Stock Up 1.8%

Astera Labs stock traded up $2.49 during trading hours on Wednesday, hitting $142.01. The stock had a trading volume of 4,170,056 shares, compared to its average volume of 5,264,290. The stock’s 50-day moving average price is $190.50 and its 200-day moving average price is $145.33. The stock has a market capitalization of $23.99 billion, a P/E ratio of 127.94, a price-to-earnings-growth ratio of 2.64 and a beta of 1.37. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same quarter last year, the firm earned $0.23 earnings per share. The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the topic of several recent analyst reports. Morgan Stanley increased their price objective on Astera Labs from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Bank of America assumed coverage on Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price for the company. JPMorgan Chase & Co. upped their target price on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Finally, Jefferies Financial Group boosted their price objective on shares of Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average price target of $184.82.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ALAB. Assetmark Inc. increased its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Oliver Lagore Vanvalin Investment Group purchased a new stake in Astera Labs in the second quarter worth about $29,000. Bernard Wealth Management Corp. bought a new position in shares of Astera Labs in the second quarter worth about $36,000. National Bank of Canada FI raised its stake in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares during the period. Finally, Wexford Capital LP purchased a new position in shares of Astera Labs during the 3rd quarter valued at about $39,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.